Genetesis Accelerated Registry (GEAR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05051228|
Recruitment Status : Recruiting
First Posted : September 21, 2021
Last Update Posted : September 21, 2021
|Condition or disease||Intervention/treatment|
|Acute Myocardial Infarction Acute Coronary Syndrome||Device: CardioFlux|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Genetesis Accelerated Registry|
|Actual Study Start Date :||January 27, 2021|
|Estimated Primary Completion Date :||July 2022|
|Estimated Study Completion Date :||July 2022|
This is a noninvasive study that screens healthy and non-healthy volunteers for cardiovascular disease.
Magnetocardiography (MCG) is a noninvasive method that measure the magnetic field that arises from the electrical activity of the heart cycle.
- Accuracy of Cardioflux diagnosis/screening of ACS [ Time Frame: 12 months ]Comparing the accuracy of Cardioflux to current standard of care when diagnosing/screening for ACS
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05051228
|Contact: Anthony Senagore, MDemail@example.com|
|Contact: Samantha Legreaux, M.S.||firstname.lastname@example.org|
|United States, Ohio|
|Mason, Ohio, United States, 45040|
|Contact: Samantha Legreaux, M.S. 513-715-5045 email@example.com|